dermatology
Medicines

Precautionary approach advised with immunomodulators during COVID-19

Interim advice on the management of patients with severe dermatological disease says most patients should continue to take their immunomodulator therapy against a background of the COVID-19 pandemic. However in patients with confirmed COVID-19 disease, immunomodulators should be stopped immediately, with the possible exception of systemic corticosteroids where sudden stopping was unwise. “There is little ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic